Relay Therapeutics is trading 4.3% up now at $20.72, with the reason for the gain remaining unconfirmed.
- Searches found no new company-specific announcement, clinical update, analyst action, or other clear catalyst dated August 17, 2026.
- The latest identifiable company news was second-quarter financial results released August 6; reported volume was below average in available market coverage.
- Major indexes were modestly lower rather than strongly rising, so broader market momentum does not clearly explain the gain.